| Financial Ratios | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Return on Equity | 72.807 | 12.399 | 12.849 | 16.243 |
| Net Profit Margin | -1,431.439 | -161.797 | -209.766 | -350.255 |
| Debt to Asset Ratio | 234.407 | 199.537 | 200.852 | 241.719 |
| Cash Ratio | 301.969 | 143.042 | 105.438 | 271.815 |
| Quick Ratio | 665.773 | 508.412 | 564.977 | 397.86 |
| Current Ratio | 666.578 | 509.886 | 576.709 | 410.971 |
ImmunityBio, Inc. (IBRX)
ImmunityBio, Inc. (IBRX)